The P2X7 Receptor in Infection and Inflammation

Di Virgilio, Francesco, Dal Ben, Diego, Sarti, Alba Clara, Giuliani, Anna Lisa, Falzoni, Simonetta·2017·Immunity

Cited by (1,000)

Items 501–600 of 1,000

  1. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
    Deidiane Elisa Ribeiro, Lyvia Lintzmaier Petiz, Talita Glaser, Ágatha Oliveira‐Giacomelli, Roberta Andrejew, Fernando de Azevedo Ribeiro Saab, Milena da Silva Milanis, Henrique Correia Campos, Vanessa Fernandes Arnaud-Sampaio, Sophia La Banca de Oliveira et al. · 2022 · Neuropharmacology
  2. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection
    Déborah Lécuyer, Roberta Nardacci, Désirée Tannous, Emie Gutierrez-Mateyron, Aurélia Deva Nathan, Frédéric Subra, Cristina Di Primio, Paola Quaranta, Vanessa Petit, Clémence Richetta et al. · 2023 · Frontiers in Immunology
  3. T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections
    Igor Santiago-Carvalho, Gislane de Almeida Santos, Bruna de Gois Macedo, Caio César Barbosa Bomfim, Fabrício Moreira Almeida, Marcos Vinícios Pinheiro Cione, Trupti Vardam-Kaur, Mia Y. Masuda, Sarah van Dijk, Bruno Marcel Silva de Melo et al. · 2023 · Cell Reports
  4. Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective
    Kartik Panbhare, Rukmani Pandey, Chandan Chauhan, Antarip Sinha, Rahul Shukla, Ravinder Kumar Kaundal · 2023 · ACS Chemical Neuroscience
  5. Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
    Diego Dal Ben, Luca Antonioli, Catia Lambertucci, Matteo Fornai, Corrado Blandizzi, Rosaria Volpini · 2018 · Frontiers in Pharmacology
  6. Proximal femoral head transcriptome reveals novel candidate genes related to epiphysiolysis in broiler chickens
    Jane de O. Peixoto, Igor Ricardo Savoldi, A. M. G. Ibelli, Maurício Egídio Cantão, Fátima R.F. Jaenisch, P. F. Giachetto, Matthew Lee Settles, Ricardo Zanella, Jorge Augusto Petroli Marchesi, J. R. C. Pandolfi et al. · 2019 · BMC Genomics
  7. Non-coding RNA regulators of diabetic polyneuropathy
    Chanan Meydan, Nurcan Üçeyler, Hermona Soreq · 2020 · Neuroscience Letters
  8. Protein disulfide isomerase-mediated S-nitrosylation facilitates surface expression of P2X7 receptor following status epilepticus
    Duk-Shin Lee, Ji-Eun Kim · 2021 · Journal of Neuroinflammation
  9. Blocking the ART2.2/P2X7‐system is essential to avoid a detrimental bias in functional CD4 T cell studies
    Georgiev, Hristo, Ravens, Inga, Papadogianni, Georgia, Malissen, Bernard, Förster, Reinhold, Bernhardt, Günter · 2018 · European Journal of Immunology
  10. Adenosine diphosphate released from stressed cells triggers mitochondrial transfer to achieve tissue homeostasis
    Hao Li, Hongping Yu, Delin Liu, Peng Liao, Chuan Gao, Jian Zhou, Jialun Mei, Zong Yao, Peng Ding, Meng Yao et al. · 2024 · PLoS Biology
  11. Molecular Mechanisms of Rett Syndrome: Emphasizing the Roles of Monoamine, Immunity, and Mitochondrial Dysfunction
    Júlia Lopes Gonçalez, Jenny Shen, Wei Li · 2024 · Cells
  12. Interaction Between Autophagy and Porphyromonas gingivalis-Induced Inflammation
    Sen Kang, Anna Dai, Huiming Wang, Pei‐Hui Ding · 2022 · Frontiers in Cellular and Infection Microbiology
  13. Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions
    Bing-xin Sun, Aishi Peng, Peijie Liu, Min‐Jia Wang, Haili Ding, Yushi Hu, Liang Kang · 2022 · Purinergic Signalling
  14. Continued P2X7 activation leads to mitochondrial fission and compromising microglial phagocytosis after subarachnoid haemorrhage
    Tao Tao, Xiangxin Chen, Yan Zhou, Qiang Zheng, Sen Gao, Jinwei Wang, Peng-Fei Ding, Xiaojian Li, Zheng Peng, Yue Lu et al. · 2022 · Journal of Neurochemistry
  15. Animal models and human tissue compared to better understand and treat the epilepsies
    Giampaolo Milior, Mélanie Morin‐Brureau, Johan Pallud, Richard Miles, Gilles Huberfeld · 2023 · Epilepsia
  16. P2X7 receptor antagonist A-438079 alleviates oxidative stress of lung in LPS-induced septic rats
    Seçkin Özkanlar, Nergis Ulaş, Özgür Kaynar, Emine Satıcı · 2023 · Purinergic Signalling
  17. Cytokine storm in human monkeypox: A possible involvement of purinergic signaling
    Gilnei Bruno da Silva, Geórgia de Carvalho Braga, Júlia Leão Batista Simões, Aniela Pinto Kempka, Margarete Dulce Bagatini · 2024 · Cytokine
  18. cGAMP promotes inner blood-retinal barrier breakdown through P2RX7-mediated transportation into microglia
    Xiangyu Ge, Xingfei Zhu, Wei Liu, Mingsen Li, Zhaotian Zhang, Ming Zou, Mi Deng, Haifeng Cui, Ziqing Chen, Li Wang et al. · 2025 · Journal of Neuroinflammation
  19. Sex-specific effects of gain-of-function P2RX7 variation on bipolar disorder
    Stacey J. Winham, William Victor Bobo, Jiajia Liu, Brandon J. Coombes, Lena Backlund, Mark A. Frye, Joanna M. Biernacka, Martin Schalling, Catharina Lavebratt · 2018 · Journal of Affective Disorders
  20. Purinergic Signaling and Cochlear Injury-Targeting the Immune System?
    László Köles, Judit Szepesy, Eszter Berekméri, Tibor Zelles · 2019 · International Journal of Molecular Sciences
  21. Self-Regulation of Memory CD8 T Cell Metabolism through Extracellular ATP Signaling
    Kelsey M Wanhainen, S. Jameson, H. B. da Silva · 2019 · Immunometabolism
  22. Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease
    Iva Hlapčić, Andrea Hulina, Anita Somborac Bačura, Marija Grdić Rajković, Andrea Vukić Dugac, Sanja Popović‐Grle, Lada Rumora · 2019 · Scientific Reports
  23. Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets
    Kelly Juliana Filippin, Kamylla Fernanda Souza de Souza, Roberto Theodoro de Araujo Júnior, Heron Fernandes Vieira Torquato, Dhébora Albuquerque Dias, Eduardo Benedetti Parisotto, Alice Teixeira Ferreira, Edgar Julian Paredes‐Gamero · 2019 · Purinergic Signalling
  24. Evolutionary Origin of the P2X7 C-ter Region: Capture of an Ancient Ballast Domain by a P2X4-Like Gene in Ancient Jawed Vertebrates
    Airi Rump, Olli‐Pekka Smolander, Sirje Rüütel Boudinot, Jean Kanellopoulos, Pierre Boudinot · 2020 · Frontiers in Immunology
  25. Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
    Melanie Demeules, A. Scarpitta, C. Abad, H. Gondé, R. Hardet, Carolina Pinto-Espinoza, A. Eichhoff, Waldemar Schäfer, F. Haag, F. Koch-Nolte et al. · 2020 · Frontiers in Oncology
  26. Editorial: DAMPs Across the Tree of Life
    Seung‐Yong Seong, Polly Matzinger, Walter Gottlieb Land · 2022 · Frontiers in Immunology
  27. Quercetin Mitigates Lysophosphatidylcholine (LPC)-Induced Neutrophil Extracellular Traps (NETs) Formation through Inhibiting the P2X7R/P38MAPK/NOX2 Pathway
    Si Liu, Yan Wang, Linyao Ying, Hao Li, Keyi Zhang, Na Liang, Gang Luo, Lin Xiao · 2024 · International Journal of Molecular Sciences
  28. Recent strategies in target identification of natural products: Exploring applications in chronic inflammation and beyond
    Xian Ming Pan, Shan Jiang, Xinzhuang Zhang, Zhenzhong Wang, Xin Wang, Liang Cao, Wei Xiao · 2024 · British Journal of Pharmacology
  29. Purinergic-associated immune responses in neurodegenerative diseases
    Sara Carracedo, Agathe Launay, Paul-Alexandre Déchelle-Marquet, Émilie Faivre, David L Blum, Cécile Delarasse, Éric Boué‐Grabot · 2024 · Progress in Neurobiology
  30. DAMP signaling networks: from receptors to diverse pathophysiological functions
    Ruochan Chen, Ju Zou, Xiao Yan Zhong, Jiao Liu, Rui Kang, Daolin Tang · 2025 · Journal of Advanced Research
  31. Pathophysiology of Status Epilepticus Revisited
    Rawiah S. Alshehri, Moafaq S. Alrawaili, Basma M. H. Zawawi, Majed Alzahrany, Alaa Hamed Habib · 2025 · International Journal of Molecular Sciences
  32. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder
    Javier Garrosa, Yolanda Sánchez‐Carro, María Carmen Ovejero-Benito, Eric del Sastre, Antonio G. Garcı́a, Manuela G. López, Pilar López-García, María F. Cano‐Abad · 2021 · Neuroscience Letters
  33. Title: P2x7 Receptor Activation and Estrogen Status Drive Neuroinflammatory Mechanisms in a Rat Model for Dry Eye
    David A. Bereiter, Mostafeezur Rahman, Fabeeha Ahmed, Randall Thompson, Nhungoc Luong, Julie K. Olson · 2022 · Frontiers in Pharmacology
  34. P2X7-dependent immune pathways in retinal diseases
    Paul-Alexandre Déchelle-Marquet, Xavier Guillonneau, Florian Sennlaub, Cécile Delarasse · 2022 · Neuropharmacology
  35. The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside
    Iven-Alex von Mücke-Heim, Jan M. Deussing · 2022 · Neuropharmacology
  36. P2X7-NLRP3-Caspase-1 signaling mediates activity-induced muscle pain in male but not female mice
    Kazuhiro Hayashi, Joseph B. Lesnak, Ashley N. Plumb, Lynn A. Rasmussen, Kathleen Anne Sluka · 2023 · Pain
  37. The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
    Yu-ting Zou, Jinyuan Li, Jun-yi Chai, Yushan Hu, Wenjun Zhang, Qiao Zhang · 2024 · Biochemical and Biophysical Research Communications
  38. Dysregulation of Astrocytic ATP/Adenosine Release in the Hippocampus Cause Cognitive and Affective Disorders: Molecular Mechanisms, Diagnosis, and Therapy
    Péter Illés, Patrizia Rubini, Henning Ulrich, Haiyan Yin, Yong Cheng Tang · 2025 · MedComm
  39. Molecular mechanism underlying the subtype-selectivity of competitive inhibitor NF110 and its distinct potencies in human and rat P2X3 receptors
    Bin Li, Jin Qiang Wang, Xiaoyang Cheng, Yan Liu, Yang Yang, Xiaona Yang, Chang-Run Guo, Youya Niu, Peng Cao, Xiangyang Lu et al. · 2018 · 中国科学通报:英文版
  40. P2RX7 Deletion in T Cells Promotes Autoimmune Arthritis by Unleashing the Tfh Cell Response
    Krysta M. Felix, Fei Teng, Nicholas A. Bates, Heqing Ma, Ivan A. Jaimez, Kiah C. Sleiman, Nhan L. Tran, Hsin-Jung Joyce Wu · 2019 · Frontiers in Immunology
  41. The current role of NLRP3 inflammasome polymorphism in gout susceptibility
    Denise Clavijo‐Cornejo, Olivia Hernández‐González, Marwin Gutiérrez · 2021 · International Journal of Rheumatic Diseases
  42. Variations in Cellular Responses of Mouse T Cells to Adenosine-5′-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage
    Hanaa Safya, Amine Mellouk, Julie Legrand, Sylvain M. Le Gall, Mohcine Benbijja, Colette Kanellopoulos‐Langevin, Jean Kanellopoulos, Pierre Bobé · 2018 · Frontiers in Immunology
  43. P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: Role of the A2A/CD39/CD73 axis
    Anna Pegoraro, Elena De Marchi, Luigia Ruo, Michele Zanoni, Sofia Chioccioli, Giovanna Caderni, Letizia Alfieri, Marianna Grignolo, Paola Ulivi, Alessandro Passardi et al. · 2025 · Cell Death and Disease
  44. P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia
    Stefano Calovi, Paula Mut-Arbona, Pál Tod, András Iring, Annette Nicke, Susana Mato, E. Sylvester Vizi, Jan Tønnesen, Beáta Sperlágh · 2020 · Frontiers in Molecular Neuroscience
  45. Herb-partitioned moxibustion alleviates colonic inflammation in Crohn’s disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway
    Ji Zhang, Xue-jun Wang, Li-jie Wu, Ling Yang, Yan-ting Yang, Dan Zhang, Jue Hong, Xi-ying Li, Xiao-qing Dong, Xiao-cong Guo et al. · 2021 · PLoS ONE
  46. P2X7 receptor is essential for cross-dressing of bone marrow-derived dendritic cells
    Carlos Barrera‐Avalos, Pedro Briceño, Daniel Valdés, Mónica Imarai, Elías Leiva‐Salcedo, Leonel E. Rojo, Luis A. Milla, Juan Pablo Huidobro-Toro, Claudia Robles-Planells, Alejandro F. Escobar et al. · 2021 · iScience
  47. Purinergic Signaling in the Regulation of Gout Flare and Resolution
    Xiaoling Li, Jie Gao, Jin‐Hui Tao · 2021 · Frontiers in Immunology
  48. Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases
    Qimin An, Gengyu Yue, Xiaoxu Yang, Jun Lou, Weixi Shan, Jianhong Ding, Zhe Jin, Yanxia Hu, Qian Du, Qiushi Liao et al. · 2021 · Frontiers in Physiology
  49. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy
    Zheng Wei Wong, Tobías Engel · 2022 · Neuropharmacology
  50. Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
    Franca Rosa Guerini, Cristina Agliardi, Elisabetta Bolognesi, Milena Zanzottera, Domenico Caputo, Maria Barbara Pasanisi, Marco Rovaris, Mario Clerici · 2022 · International Journal of Molecular Sciences
  51. Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system—No evidence for the role of neuronal P2X7 receptors in colitis
    Tina Jooss, Jiong Zhang, Béla Zimmer, Tanja Rezzonico-Jost, Björn Rissiek, Penelope Pelczar, Frauke Seehusen, Friedrich Koch‐Nolte, Tim Ullrich Magnus, Susanna Zierler et al. · 2023 · Mucosal Immunology
  52. Phytochemical and biological characterization of aqueous extract of Vassobia breviflora on proliferation and viability of melanoma cells: involvement of purinergic pathway
    Altevir Rossato Viana, Nathieli Bianchin Bottari, Vinícius Rodrigues Oviedo, Daniel Rocha dos Santos, James Eduardo Lago Londero, Maria Rosa Chitolina Schetinger, Érico M.M. Flores, Aline Grohe Schirmer Pigatto, André Passáglia Schuch, Alexandre Krause et al. · 2023 · Journal of Toxicology and Environmental Health
  53. The P2X7 Receptor in Autoimmunity
    Fabio Grassi, Gaia Salina · 2023 · International Journal of Molecular Sciences
  54. Evidence of a genetic background predisposing to complex regional pain syndrome type 1
    Samiha S. Shaikh, Andreas Göebel, Michael Lee, Michael S. Nahorski, Nicholas Shenker, Yunisa Pamela, Ichrak Drissi, Christopher Andrew Brown, Gillian Ison, Maliha Shaikh et al. · 2023 · Journal of Medical Genetics
  55. Molecular mechanisms of resveratrol and its silver nanoparticle conjugate in addressing sepsis-induced lung injury
    Hilal Üstündağ, Adem Kara, Songül Doğanay, Nezahat Kurt, Elif Erbaş, Ferdane Danışman Kalındemirtaş, İshak Afşin Kari̇per · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  56. Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels
    Dorina Zöphel, Chantal Hof, Annette Lis · 2020 · International Journal of Molecular Sciences
  57. Inflammasomes and the Maintenance of Hematopoietic Homeostasis: New Perspectives and Opportunities
    Lijing Yang, Mengjia Hu, Yukai Lu, Songling Han, Junping Wang · 2021 · Molecules
  58. Disruption of Purinergic Receptor P2X7 Signaling Increases Susceptibility to Cerebral Toxoplasmosis
    Aline Cristina Abreu Moreira-Souza, Thuany Prado Rangel, Sthefani Rodrigues Batista da Silva, Vanessa Ribeiro Figliuolo, Luiz Eduardo Baggio Savio, Felipe Schmitz, Christina Maeda Takiya, Ângela Terezinha de Souza Wyse, Rossiane Cláudia Vommaro, Robson Coutinho‐Silva · 2019 · American Journal Of Pathology
  59. Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice
    Catalina Abad, Mélanie Demeules, Charlotte Guillou, Henri Gondé, Rachid Zoubaïri, Yossan‐Var Tan, Carolina Pinto-Espinoza, Waldemar Schäfer, Anna Marei Mann, Valérie Vouret‐Craviari et al. · 2024 · Journal of Nanobiotechnology
  60. Role of damage-associated molecular patterns in the pathogenesis and therapeutics of traumatic brain injury
    Bowen Sun, Jiarui Zhang, Zhiqiang Li, Jialu Wang, Chuansheng Zhao, Xiaoxue Xu · 2025 · Burns & Trauma
  61. Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
    Eugenia A. Ahremenko, Alexander Andreev, Danila Apushkin, Eduard Korkotian · 2025 · International Journal of Molecular Sciences
  62. Diphenyleneiodonium enhances P2X7 dependent non-opsonized phagocytosis and suppresses inflammasome activation via blocking CX43-mediated ATP leakage
    Yuanfeng Zhu, Xiaoli Chen, Yongling Lu, Shijun Fan, Yongjun Yang, Qian Chen, Qianying Huang, Lin Xia, Wei Yan, Jiang Zheng et al. · 2021 · Pharmacological Research
  63. Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists
    Marius Patberg, Andreas Isaak, Friederike T. Füsser, Natalia V. Ortiz Zacarı́as, Laura Vinnenberg, Janine Schulte, Lucia Michetti, Lucie Grey, Cas van der Horst, Petra Hundehege et al. · 2021 · European Journal of Medicinal Chemistry
  64. Context-dependent regulation of follicular helper T cell survival.
    Zhian Chen, Nai-Qi Wang, Yin Yao, Di Yu · 2022 · Trends in immunology
  65. The Purinergic Landscape of Type 2 Diabetes Mellitus
    R.E. García-Jacobo, Letícia Scussel Bergamin, Valentina Vultaggio-Poma, Maria Luiza Thorstenberg, Mario Tarantini, Mariana Haydee García-Hernández, Francesco Di Virgilio · 2022 · Molecules
  66. Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo
    Melanie Demeules, A. Scarpitta, R. Hardet, H. Gondé, C. Abad, Marine Blandin, Stephan Menzel, Yinghui Duan, B. Rissiek, T. Magnus et al. · 2022 · Frontiers in Immunology
  67. ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use
    Rafael Olivé Leite, Priscila Oliveira de Souza, Clarissa Branco Haas, Fernando da Silveira, Kauan Mohr, Ana Paula Santin Bertoni, Mayara Sandrielly Pereira Soares, Juliana H. Azambuja, Morgana Dal Prá, Lorraynne Letycia Prado da Cruz et al. · 2023 · Clinical and Experimental Medicine
  68. Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies
    Alan Rawls, Bridget K. Diviak, Cameron I. Smith, Grant W. Severson, Sofia A. Acosta, Jeanne Wilson‐Rawls · 2023 · Biomolecules
  69. Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis
    Julien Nadjar, Sylvain Monnier, Estelle Bastien, Anne‐Laure Huber, Christiane I. Oddou, Léa Bardoulet, Hubert B. Leloup, Gabriel Ichim, Christophe Vanbelle, Bénédicte F. Py et al. · 2024 · Science Signaling
  70. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity
    Li Wang, Limin Cao, Zhihong Li, Zhugui Shao, Xia Chen, Zhicheng Huang, Xiaoxiao He, Junke Zheng, L.-Z. Liu, Xin‐Ming Jia et al. · 2024 · The Journal of Immunology
  71. Alzheimer’s disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles
    Seyyed-Sam-Mehdi Hosseininasab, Rasoul Ebrahimi, Shirin Yaghoobpoor, Kiarash Kazemi, Yaser Khakpour, Ramtin Hajibeygi, Ashraf Mohamadkhani, M. Fathi, Kimia Vakili, A. Tavasol et al. · 2025 · Frontiers in Neuroscience
  72. Insights into the Structure-Activity Relationship of Glycosides as Positive Allosteric Modulators Acting on P2X7 Receptors
    Waraporn Piyasirananda, Andrew Michael Beekman, Arasu Ganesan, Stefan M. Bidula, Leanne Stokes · 2020 · Molecular Pharmacology
  73. Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets
    Maria Luiza Mukai Franciosi, Thiago Inácio Teixeira do Carmo, Daniela Zanini, Andréia Machado Cardoso · 2022 · Inflammation Research
  74. Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
    Shuyin Bao, Xiuzhi Wang, Qianqian Ma, Cheng‐Xi Wei, Ji‐Xing Nan, Wuliji Ao · 2022 · Chinese Herbal Medicines
  75. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice
    Makiko Koike-Kumagai, Manabu Fujimoto, Mari Wataya‐Kaneda · 2022 · Neuropharmacology
  76. Effects of Resvega on Inflammasome Activation in Conjunction with Dysfunctional Intracellular Clearance in Retinal Pigment Epithelial (RPE) Cells
    Niina Bhattarai, Niina Piippo, Sofia Ranta‐aho, Yashavanthi Mysore, Kai Kaarniranta, Anu Kauppinen · 2021 · Antioxidants
  77. Priming and release of cytokine IL-1β in microglial cells from the retina
    Keith E. Campagno, Wennan Lu, Puttipong Sripinun, Farraj Albalawi, Aurora Cenaj, Claire H. Mitchell · 2025 · Experimental Eye Research
  78. Mechanisms of astrocytic and microglial purinergic signaling in homeostatic regulation and implications for neurological disease
    Moawiah M. Naffaa · 2025 · Exploration of neuroscience
  79. P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells
    Valentina Vultaggio-Poma, Francesco Di Virgilio · 2022 · Biomolecules
  80. Extracellular ATP and its derivatives provide spatiotemporal guidance for bone adaptation to wide spectrum of physical forces
    Chrisanne Dsouza, Mahmoud Moussa, Nicholas Mikolajewicz, Svetlana V. Komarova · 2022 · Bone Reports
  81. Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia
    Mariangela Chisari, Michele Barraco, Claudio Bucolo, Lucia Ciranna, Maria Angela Sortino · 2022 · European Journal of Pharmacology
  82. The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
    Ming-Yan Shi, Han-Ge Liu, Xiao-Hong Chen, Ye Tian, Zhi‐Nan Chen, Xiuli Wang · 2023 · Frontiers in Immunology
  83. The potential role of T-cell metabolism-related molecules in chronic neuropathic pain after nerve injury: a narrative review
    Xiaoke Dou, Rui Chen, Juexi Yang, Maosha Dai, Junhao Long, Shujun Sun, Yun Lin · 2023 · Frontiers in Immunology
  84. The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
    Valentina Vultaggio-Poma, Juana María Sanz, Andrea Amico, Alessandra Violi, Sara Ghisellini, Stefano Pizzicotti, Angelina Passaro, Alberto A. Papi, Marco Libanore, Francesco Di Virgilio et al. · 2023 · Frontiers in Immunology
  85. P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy
    Qian Cheng, Jiayue Lu, Xiajing Che, Lulin Min, Minzhou Wang, Ahui Song, Leyi Gu, Leyi Gu, Kewei Xie · 2023 · Free Radical Biology and Medicine
  86. Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.
    Tijana Randic, S. Magni, D. Philippidou, C. Margue, K. Grzyb, J. Preis, Joanna Patrycja Wróblewska, P. Nazarov, Michel Mittelbronn, Katrin B. M. Frauenknecht et al. · 2023 · Cell Reports
  87. Taurodeoxycholate ameliorates DSS-induced colitis in mice
    Yunyun Zou, Aziz Ghaderpour, Bolormaa Munkhbileg, Sang‐Uk Seo, Seung‐Yong Seong · 2023 · International Immunopharmacology
  88. P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis
    Lluis Lis-López, C Bauset, Marta Seco-Cervera, Dulce C. Macias-Ceja, Francisco Navarro, Ángeles Álvarez, Juan Vicente Esplugues, Sara Calatayud, M D Barrachina, D Ortiz‐Masiá et al. · 2023 · International Journal of Molecular Sciences
  89. Ion channel P2X7 receptor in the progression of cancer
    Guangping Zhang, Jun-xiang Liao, Yi-yi Liu, Fu-qi Zhu, Hui-jin Huang, Wenjun Zhang · 2024 · Frontiers in Oncology
  90. An explanation of the role of pyroptosis playing in epilepsy
    Xuefei Zhang, Ting Zhao, Songxue Su, Lei Li, Yubing Zhang, Jiangyu Yan, Xiaoxiao Cui, Yanyan Sun, Jianyuan Zhao, Xiong Han et al. · 2024 · International Immunopharmacology
  91. Activation of dendritic cells by targeted DNA: a potential addition to the armamentarium for anti-cancer immunotherapy
    Marlene Fyrstenberg Laursen, Emil Kofod‐Olsen, Ralf Agger · 2019 · Cancer Immunology Immunotherapy
  92. Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
    Cinzia Volonté, Susanna Amadio, Francesco Liguori, Paola Fabbrizio · 2020 · Frontiers in Pharmacology
  93. Metabolic Regulation of Tissue-Resident Memory CD8+ T cells
    Trupti Vardam-Kaur, Jie Sun, Henrique Borges da Silva · 2021 · Current opinion in pharmacology (Print)
  94. Quantitative phosphoproteomics reveals ectopic ATP synthase on mesenchymal stem cells to promote tumor progression via ERK/c-Fos pathway activation
    Yi‐Wen Chang, Chia‐Chi Wang, Chieh-Fan Yin, Chang-Hsun Wu, Hsuan‐Cheng Huang, Hsueh‐Fen Juan · 2022 · Molecular & Cellular Proteomics
  95. Chronic Intermittent Hypoxia‐Induced Neural Injury: Pathophysiology, Neurodegenerative Implications, and Therapeutic Insights
    Nan‐Nan Jia, Meng‐Fan Yao, Chun‐Xue Zhu, Mengzi He, Hai‐Feng Zhu, Zun‐Yu Chen, Hanpeng Huang, Qiao Chen · 2025 · CNS Neuroscience & Therapeutics
  96. Possible Interaction of Suramin with Thalamic P2X Receptors and NLRP3 Inflammasome Activation Alleviates Reserpine-Induced Fibromyalgia-Like Symptoms
    Maram M. Mohamed, Hala Fahmy Zaki, Ahmed Seif El Din Kamel · 2025 · Journal of Neuroimmune Pharmacology
  97. Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to Therapy
    Si‐Qi Ding, Yun Lei, Zhe‐Ming Zhao, Xin‐Yun Li, Ji‐Xuan Lang, Jia‐Kui Zhang, Yanan Li, Chun‐Dong Zhang, Dong‐Qiu Dai · 2025 · Comprehensive physiology
  98. Characterization of equine inflammasomes and their regulation
    Huijeong Ahn, Jeongeun Kim, Hansae Lee, Eunsong Lee, Geun‐Shik Lee · 2020 · Veterinary Research Communications
  99. P2X7 Receptor and Heart Function in a Mouse Model of Systemic Inflammation Due to High Fat Diet
    Francesco Raggi, Chiara Rossi, Francesco Faita, Mariarosaria Distaso, Claudia Kusmic, Anna Solini · 2022 · Journal of Inflammation Research
  100. Single channel properties of pannexin‐1 and connexin‐43 hemichannels and P2X7 receptors in astrocytes cultured from rodent spinal cords
    Juan Mauricio Garré, Feliksas F. Bukauskas, Michael V. L. Bennett · 2022 · Glia